Williams & Connolly LLP

Williams & Connolly LLP has a strong track record in business-critical patent litigation cases at both the trial and appellate levels. Along with its expertise in defending technology patents, the team demonstrates a particular strength in the life sciences space. Recently, they successfully represented Pfizer in three inter partes reviews (IPRs) and have handled various Hatch-Waxman cases for AstraZeneca. The Washington DC-based team is co-chaired by David Berl, a seasoned lead counsel with a focus on patents in the biotech, pharma and energy sectors, and Jessamyn Berniker, who has significant experience in patent litigation across the pharma, medical device and electronics industries. Thomas Selby brings value expertise related to cases at the intersection of the life sciences and technology sectors. Stanley Fisher is sought after by tech companies for his knowledge of patent and antitrust issues. Dov Grossman is also a key practitioner, particularly for biopharma companies. Elise M. Baumgarten and Shaun P. Mahaffy offer further support, with both specializing in Hatch-Waxman cases.